Fda Stock Market Invest

Companies
FDA Greenlights Injectable Form of Roche's MS Therapy, Impact on Market Evaluated Sep 14, 2024
Stocks
Zydus Lifesciences Shares Surge on FDA Approval for Parkinson's Medication Aug 28, 2024
Companies
Sysco Spearheads Industry Compliance with FSMA Food Traceability Rule Aug 20, 2024
Pharmaceuticals
SpringWorks Therapeutics Submits NDA for Mirdametinib to the FDA Jul 2, 2024
Companies
FDA Issues Warning to Dollar Tree, Affecting DLTR Stock Jun 19, 2024
Pharmaceuticals
Ipsen's Iqirvo® Granted Accelerated FDA Approval for Primary Biliary Cholangitis Treatment Jun 11, 2024
Biotech
FDA Accepts Eisai's LEQEMBI® Supplemental Biologics License Application for Alzheimer's Jun 10, 2024
Pharmaceuticals
FDA Prioritizes Review of Dupixent for COPD with Type 2 Inflammation, a Potential Breakthrough by Regeneron and Sanofi Jun 1, 2024
Companies
QIAGEN (QGEN) Secures FDA Approval for Advanced Respiratory Test Panel May 15, 2024
Pharmaceuticals
MannKind Gains FDA Approval to Commence Phase 3 Trials for NTM Treatment Apr 30, 2024
Pharmaceuticals
Wegovy® Gains FDA Approval for Cardiovascular Risk Reduction in Overweight or Obese Patients with Cardiovascular Disease Mar 9, 2024
Pharmaceuticals
Incannex Advances Tobacco Cessation Aids with FDA Pre-IND Success for CannQuit-N Feb 17, 2024
Government
FDA Approves Florida's Groundbreaking Plan to Import Prescription Drugs from Canada Jan 6, 2024
Stocks
Cingulate Inc. Shares Surge on Positive FDA Guidance for ADHD Drug Candidate Dec 29, 2023
Pharmaceuticals
FDA Completes Review of Amgen's Supplemental Application for LUMAKRAS® (sotorasib) Dec 27, 2023
Stocks
Pre-Market Surge for ReShape Lifesciences as FDA Approves Lap-Band 2.0 FLEX; Multiple Stocks on the Move Dec 14, 2023
Stocks
Vanda Pharmaceuticals Soars on FDA Acceptance of Gastroparesis Drug NDA Dec 6, 2023
Biotech
Immix Biopharma Receives FDA Nod for CAR-T Cell Therapy IND, Eyes U.S. Treatment Commencement Nov 21, 2023